Clinical Trial Detail

NCT ID NCT02050321
Title A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Arizona
Indications

melanoma

Therapies

Acitretin + Vemurafenib

Age Groups: adult

Additional content available in CKB BOOST